KC
IDXX icon

Kepos Capital’s Idexx Laboratories IDXX Stock Holding History

Kepos Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,989
Closed -$1.04M – 243
2019
Q4 		$1.04M Buy
+3,989
New +$1.05M 0.1% 122
2019
Q3 		– Sell
-10,681
Closed -$2.94M – 356
2019
Q2 		$2.94M Buy
+10,681
New +$2.63M 0.3% 51
2019
Q1 		– Sell
-35,934
Closed -$6.68M – 365
2018
Q4 		$6.68M Buy
35,934
+18,126
+102% +$3.72M 0.52% 32
2018
Q3 		$4.45M Buy
17,808
+851
+5% +$207K 0.23% 101
2018
Q2 		$3.7M Buy
16,957
+8,312
+96% +$1.71M 0.19% 122
2018
Q1 		$1.66M Buy
8,645
+5,797
+204% +$1.07M 0.1% 145
2017
Q4 		$445K Hold
2,848
– – 0.04% 169
2017
Q3 		$443K Buy
+2,848
New +$450K 0.07% 83

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Kepos Capital's IDXX Position: Q1 2020 in Review

Kepos Capital sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 3,989 shares — an estimated $1.04M sold.

Kepos Capital first reported a position in IDXX in Q3 2017 and held it in 8 quarters. The position peaked at $6.68M in Q4 2018. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Kepos Capital reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 3,989 Idexx Laboratories shares in Q1 2020, an estimated $1.04M.
  • Kepos Capital first reported a position in Idexx Laboratories in Q3 2017 and held it in 8 quarters.
  • Kepos Capital's Idexx Laboratories position peaked at $6.68M in Q4 2018.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.